Following positive Phase 1 trial results, fibrin
Author: Michael
Continued development of Oviva’s platform to i
New research reveals how disrupted mitochondrial
New research reveals senescence is not a single
ZyVersa’s inflammasome inhibitor shown to addr
Tomorrow Bio CEO & Cofounder Emil Kendziorra on
New study finds that up to 124,000 premature dea
Light-based therapy for Parkinson’s disease mo
Company targets US regulatory approval for ‘mi
Ossium Health CEO Kevin Caldwell on reengineerin